These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5162177)

  • 21. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Generalized Alzheimer's neurofibrillary lesions without senile plaques. (Presentation of one anatomo-clinical case)].
    Constantinidis J; Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1967; 100(1):117-30. PubMed ID: 6059112
    [No Abstract]   [Full Text] [Related]  

  • 23. [Postencephalitic parkinsonism--case of parkinsonism caused by encephalitis other than Economo's disease].
    Yamamoto T
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):920-5. PubMed ID: 5753737
    [No Abstract]   [Full Text] [Related]  

  • 24. Juvenile parkinsonism--some clinical, pharmacological, and neuropathological aspects.
    Yokochi M; Narabayashi H; Iizuka R; Nagatsu T
    Adv Neurol; 1984; 40():407-13. PubMed ID: 6141711
    [No Abstract]   [Full Text] [Related]  

  • 25. Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations.
    Powell HC; London GW; Lampert PW
    J Neuropathol Exp Neurol; 1974 Jan; 33(1):98-106. PubMed ID: 4812327
    [No Abstract]   [Full Text] [Related]  

  • 26. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for neurogenesis in the adult mammalian substantia nigra.
    Zhao M; Momma S; Delfani K; Carlen M; Cassidy RM; Johansson CB; Brismar H; Shupliakov O; Frisen J; Janson AM
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7925-30. PubMed ID: 12792021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuropathology of manganese-induced Parkinsonism.
    Perl DP; Olanow CW
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):675-82. PubMed ID: 17882011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic evaluation of the substantia nigra.
    McRitchie DA; Halliday GM; Pamphlett R
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):228-32. PubMed ID: 8804024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    Anglade P; Vyas S; Javoy-Agid F; Herrero MT; Michel PP; Marquez J; Mouatt-Prigent A; Ruberg M; Hirsch EC; Agid Y
    Histol Histopathol; 1997 Jan; 12(1):25-31. PubMed ID: 9046040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.
    Hattori N; Ikebe S; Tanaka M; Ozawa T; Mizuno Y
    Adv Neurol; 1993; 60():292-6. PubMed ID: 8380521
    [No Abstract]   [Full Text] [Related]  

  • 32. Dementia in Parkinson's disease. Morphometric data.
    Duyckaerts C; Gaspar P; Costa C; Bonnet AM; Hauw JJ
    Adv Neurol; 1993; 60():447-55. PubMed ID: 8420169
    [No Abstract]   [Full Text] [Related]  

  • 33. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.
    Banati RB; Daniel SE; Blunt SB
    Mov Disord; 1998 Mar; 13(2):221-7. PubMed ID: 9539333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Key points in the neuropathological study of idiopathic parkinsonism].
    Shiraki H
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):874-96. PubMed ID: 4897052
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurochemical pathology and pharmacology of brain dopamine and acetylcholine: rational basis for the current drug treatment of Parkinsonism.
    Hornykiewicz O
    Contemp Neurol Ser; 1971; 8():33-65. PubMed ID: 5162181
    [No Abstract]   [Full Text] [Related]  

  • 36. An altered histaminergic innervation of the substantia nigra in Parkinson's disease.
    Anichtchik OV; Rinne JO; Kalimo H; Panula P
    Exp Neurol; 2000 May; 163(1):20-30. PubMed ID: 10785440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Juvenile parkinsonism: its neuropathological aspects].
    Takahashi H
    No To Shinkei; 1994 Jun; 46(6):523-9. PubMed ID: 8068433
    [No Abstract]   [Full Text] [Related]  

  • 38. Individual dopaminergic neurons show raised iron levels in Parkinson disease.
    Oakley AE; Collingwood JF; Dobson J; Love G; Perrott HR; Edwardson JA; Elstner M; Morris CM
    Neurology; 2007 May; 68(21):1820-5. PubMed ID: 17515544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [L-dopa-resistant parkinsonism with cerebral atrophy: striato-nigral degeneration? 2 cases].
    Dell'Aria V; Ciannella L; Melone MA
    Acta Neurol (Napoli); 1981 Feb; 3(1):212-5. PubMed ID: 7246294
    [No Abstract]   [Full Text] [Related]  

  • 40. Iron and ferritin in substantia nigra in Parkinson's disease.
    Jellinger KA; Kienzl E; Rumpelmaier G; Paulus W; Riederer P; Stachelberger H; Youdim MB; Ben-Shachar D
    Adv Neurol; 1993; 60():267-72. PubMed ID: 8420142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.